BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17893972)

  • 1. Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center.
    Tarr T; Gyorfy B; Szekanecz E; Bhattoa HP; Zeher M; Szegedi G; Kiss E
    Ann N Y Acad Sci; 2007 Jun; 1108():76-82. PubMed ID: 17893972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The occurrence of malignancies in a Hungarian lupus population].
    Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
    Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
    Ragnarsson O; Gröndal G; Steinsson K
    Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
    Sultan SM; Ioannou Y; Isenberg DA
    Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
    Dreyer L; Faurschou M; Mogensen M; Jacobsen S
    Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of cancer among female patients with systemic lupus erythematosus in Korea.
    Kang KY; Kim HO; Yoon HS; Lee J; Lee WC; Ko HJ; Ju JH; Cho CS; Kim HY; Park SH
    Clin Rheumatol; 2010 Apr; 29(4):381-8. PubMed ID: 20041274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international cohort study of cancer in systemic lupus erythematosus.
    Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
    Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignancy in women with systemic lupus erythematosus.
    Sweeney DM; Manzi S; Janosky J; Selvaggi KJ; Ferri W; Medsger TA; Ramsey-Goldman R
    J Rheumatol; 1995 Aug; 22(8):1478-82. PubMed ID: 7473469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.
    Azrielant S; Tiosano S; Watad A; Mahroum N; Whitby A; Comaneshter D; Cohen AD; Amital H
    Immunol Res; 2017 Apr; 65(2):464-469. PubMed ID: 28091805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea.
    Bae EH; Lim SY; Han KD; Jung JH; Choi HS; Kim CS; Ma SK; Kim SW
    Lupus; 2019 Mar; 28(3):317-323. PubMed ID: 30712493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
    Lin YC; Yen JH; Chang SJ; Lin YC
    Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of malignancy in patients with systemic lupus erythematosus.
    Ramsey-Goldman R; Mattai SA; Schilling E; Chiu YL; Alo CJ; Howe HL; Manzi S
    J Investig Med; 1998 Jun; 46(5):217-22. PubMed ID: 9676054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan.
    Chen YJ; Chang YT; Wang CB; Wu CY
    Am J Med; 2010 Dec; 123(12):1150.e1-6. PubMed ID: 21183006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy in systemic lupus erythematosus.
    Abu-Shakra M; Gladman DD; Urowitz MB
    Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy in systemic lupus erythematosus: a report of five cases in a series of 96 patients.
    Lopez Dupla M; Khamashta M; Pintado Garcia V; Lavilla Uriol P; Valencia Ortega E; Gil Aguado A
    Lupus; 1993 Dec; 2(6):377-80. PubMed ID: 8136821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
    Bernatsky S; Clarke AE; Zahedi Niaki O; Labrecque J; Schanberg LE; Silverman ED; Hayward K; Imundo L; Brunner HI; Haines KA; Cron RQ; Oen K; Wagner-Weiner L; Rosenberg AM; O'Neil KM; Duffy CM; von Scheven E; Joseph L; Lee JL; Ramsey-Goldman R
    J Rheumatol; 2017 Oct; 44(10):1484-1486. PubMed ID: 28765255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
    Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
    Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus and cancer: associated or not?
    Abu-Shakra M; Ehrenfeld M; Shoenfeld Y
    Lupus; 2002; 11(3):137-44. PubMed ID: 11999878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus and the risk of malignancy.
    Cibere J; Sibley J; Haga M
    Lupus; 2001; 10(6):394-400. PubMed ID: 11434573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden.
    Nived O; Bengtsson A; Jönsen A; Sturfelt G; Olsson H
    Lupus; 2001; 10(7):500-4. PubMed ID: 11480849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.